MenaQ7 and OAC treatment
Present studies show that 45 mcg of MK-7 from MenaQ7® daily is not likely to interfere with blood-thinning medicines.42 However, individuals using warfarin/coumarins should consult their physicians regarding the simultaneous use of vitamin K rich foods or supplements. New knowledge points to the fact that arterial calcification seems to develop more readily in patients receiving oral anticoagulant treatment (OAC) such as warfarin/coumarins. In addition there also seems to be a link between arterial calcification and poor bone health43-55, as these medicines inhibit the action of K vitamins in the body.